---
schema_version: "secwatch.filing_event.v1"
accession: "0001022079-24-000153"
form_type: "8-K"
ticker: "DGX"
cik: "0001022079"
company_name: "QUEST DIAGNOSTICS INC"
filed_at: "2024-07-23T23:59:59+00:00"
generated_at: "2026-05-31T17:45:49.671114+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Quest Diagnostics beats Q2 estimates, raises full-year guidance; announces four acquisitions

## Summary
- Q2 revenues $2.397B (+2.5% YoY); reported EPS $2.03 (-1% YoY), adjusted EPS $2.35 (+2.2% YoY)
- Full-year 2024 revenue guidance raised to $9.50-9.58B; adjusted EPS raised to $8.80-9.00
- Announces four acquisitions: LifeLabs (pending), Allina Health, OhioHealth outreach labs, PathAI Diagnostics (completed)
- Base business revenue growth ~4%; driven by new customers, advanced diagnostics, healthcare utilization
- Cash from ops guided ~$1.3B; capex ~$420M; both unchanged from prior guidance

## SEC filing metadata
- accession: 0001022079-24-000153
- form_type: 8-K
- ticker: DGX
- cik: 0001022079
- company_name: QUEST DIAGNOSTICS INC
- filed_at: 2024-07-23T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1022079/000102207924000153/0001022079-24-000153-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1022079/000102207924000153/dgx-20240723.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001022079-24-000153
- JSON: https://secwatch.observer/filing/0001022079-24-000153.json
- Plain text: https://secwatch.observer/filing/0001022079-24-000153.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.